Search - tctmd.com

Displaying 201 - 220 of 307

Sort: Relevancy | Date

News Daily News

Food Insecurity Common Among Patients With ASCVD

Michael O'Riordan

August 18, 2021

News Daily News

Statin Decisions Gain From Scoring of Coronary Artery Calcium: MESA

Yael L. Maxwell

July 21, 2021

News Daily News

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

Shelley Wood

July 12, 2021

News Daily News

Less Cancer Among HF Patients Taking Statins, Registry Shows

Michael O'Riordan

June 23, 2021

News Daily News

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

Michael O'Riordan

June 18, 2021

News Daily News

ASCVD and Cancer Diagnoses Pose Potentially Deadly Costs to Patients

Caitlin E. Cox

June 16, 2021

News Daily News

AHA: Physical Activity Should First-line Therapy as BP, LDL Tick Upwards

Michael O'Riordan

June 02, 2021

News Conference News ACC 2021

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Michael O'Riordan

May 15, 2021

News Daily News

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Michael O'Riordan

April 21, 2021

News Daily News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Michael O'Riordan

March 03, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2021

Shelley Wood

March 02, 2021

News Opinion CV Team Dispatch

March 2021 News Roundup

L.A. McKeown

March 01, 2021

Podcast Heart Sounds

Top News in Cardiology: February 2021

February 24, 2021

News Daily News

Smoking, Drinking, and Drugs—All Signs Point to Earlier ASCVD

Michael O'Riordan

February 19, 2021

News Daily News

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

Todd Neale

February 01, 2021

News Daily News

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Michael O'Riordan

January 14, 2021

News Daily News

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

Shelley Wood

December 23, 2020

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

News Daily News

Increased ASCVD Risk With Inflammatory Bowel Disease Merits Team-Based Care

Caitlin E. Cox

December 08, 2020

Advertisement

Food Insecurity Common Among Patients With ASCVD

Statin Decisions Gain From Scoring of Coronary Artery Calcium: MESA

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

Less Cancer Among HF Patients Taking Statins, Registry Shows

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

ASCVD and Cancer Diagnoses Pose Potentially Deadly Costs to Patients

AHA: Physical Activity Should First-line Therapy as BP, LDL Tick Upwards

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

TCTMD’s Top 10 Most Popular Stories for February 2021

March 2021 News Roundup

Top News in Cardiology: February 2021

Smoking, Drinking, and Drugs—All Signs Point to Earlier ASCVD

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Increased ASCVD Risk With Inflammatory Bowel Disease Merits Team-Based Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content